Arun V J։ The Hidden Risks in Every Blood Bag
Arun V J, The Leader of Transfusion Medicine at Malabar Medical College, shared a post on LinkedIn:
”Why You Should Not Transfuse Blood?
I know, I know—we call it ‘Liquid Gold.’
We’re told it’s the ultimate gift of life. And in a trauma bay or a massive hemorrhage, it absolutely is.
But after years of watching clinical trends, I’m seeing a dangerous habit: ‘Frooti’ Prescribing.
Some clinicians are tossing units of blood at patients just because their ‘numbers are a little low,’ without weighing the long-term biological tax.
Before you or a loved one signs that consent form for a non-emergency transfusion, you need to know what’s actually in that bag:
- The ‘Clean’ Blood Myth
We live in 2026, but no test is perfect.
While NAT (Nucleic Acid Testing) is the gold standard for catching viruses early, many centers still rely on ELISA.
ELISA has a wider ‘window period.’
If a donor was infected recently, the test might stay silent.
You are playing a statistical game with infections the lab literally cannot see yet.
- The TRALI and Acute Risks
It’s not just a “simple rash.” TRALI (Transfusion-Related Acute Lung Injury) is the leading cause of transfusion-related death.
Your lungs suddenly fill with fluid. Your immune system sees the foreign blood and goes into a full-scale riot.
- The ‘Shadow Side’: TRIM
This is the one they rarely mention.
Transfusion-Related Immunomodulation (TRIM) is a fundamental reprogramming of your immune system.
When you pump in 500ml of foreign biological material, your “security team” (T-cells and NK cells) gets distracted.
The Fallout:
Post-Op Infections: Transfused patients have significantly higher rates of hospital-acquired pneumonia. Your body is too busy processing the ‘foreigner’ to fight the actual bacteria.
Cancer Recurrence: NK cells hunt cancer. When TRIM shuts them down, dormant cells can find a ‘green light’ to grow.
Future Debt: Taking blood today can “sensitize” you, making your body more likely to reject a life-saving kidney or heart transplant 20 years from now.
The Mentor’s Advice:
Don’t be a passive recipient.
If a transfusion is suggested and you are stable:
- Ask for the Trigger: Is this for a symptom (shortness of breath) or just a number?
- Request ‘Restrictive’ Strategy: Modern science shows staying at a hemoglobin of 7 or 8 is often safer than forcing it to 10.
- Ask about NAT: Know the quality of the screening.
Your body is better at surviving a little bit of anemia than it is at surviving a total immune shutdown.
Respect the gift, but fear the misuse.”
Stay updated with Hemostasis Today.
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies